Stack #5: Semaglutide + AOD-9604 (Appetite control + fat mobilization) Why its popular: People want the GLP-1 appetite effect plus something that targets fat. What semaglutides evidence actually looks like Semaglutide 2.4 mg once weekly has strong RCT evidence for substantial weight loss when paired with lifestyle intervention (e.g., STEP trials)
It manages dullness, evens out the complexion, and provides a natural glow while protecting against environmental damage
Gut tissue : Repairs damage to intestinal linings, potentially relieving symptoms of digestive disorders
It makes it appropriate for a different use case: the person who already controls their diet, exercises consistently, and wants a modest additional push in fat mobilization without the gastrointestinal side effects, nausea, or hormonal disruption that come with GLP-1 agonists
Many people have heard about growth Hormone peptides like Sermorelin and these medications are capable of helping individuals decrease inflammation, enhance healing time, decrease body fat, or potentially increase lean body mass
In Edinburgh, demand for private vitamin B12 injections has risen sharply as patients look for faster access than NHS pathways allow
